🔴 Sellas Life Sciences is trading 4.37% down today with no clear catalyst identified

Sellas Life Sciences is trading 4.37% down now at $12.90 after no clear company-specific catalyst emerged in available September 11, 2026 coverage.

• The latest identified announcement, published September 2, concerned planned preclinical SLS009 pancreatic-cancer data presentations at the 2026 AACR Conference.
• That announcement was not a same-day event directly explaining the decline.
• The broader market is rising; a delayed or undisclosed catalyst remains possible.